The development of hepatocellular carcinoma during long-term treatment for recurrent non-small cell lung cancer: a case report

Multiple primary malignancies (MPMs) are defined as the presence of two or more malignancies in different organs, without a subordinate relationship. Although rarely reported, hepatocellular carcinoma (HCC) occasionally presents with simultaneous or metachronous primary malignancies in other organs....

Full description

Saved in:
Bibliographic Details
Published inJournal of liver cancer Vol. 23; no. 1; pp. 230 - 234
Main Author Kang, Seong Hee
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Liver Cancer Association 01.03.2023
Korean Liver Cancer Association
대한간암학회
Subjects
Online AccessGet full text
ISSN2288-8128
2383-5001
2383-5001
DOI10.17998/jlc.2023.03.03

Cover

More Information
Summary:Multiple primary malignancies (MPMs) are defined as the presence of two or more malignancies in different organs, without a subordinate relationship. Although rarely reported, hepatocellular carcinoma (HCC) occasionally presents with simultaneous or metachronous primary malignancies in other organs. In this report, we describe a patient with lung adenocarcinoma and lymph node and bone metastases, treated with five chemotherapeutic regimens for 24 months. Changing the chemotherapy regimen based on the suspicion of metastasis of a new liver mass did not lead to improvements. This prompted a liver biopsy and a revised diagnosis of HCC. Sixth-line treatment with the concurrent use of cisplatin-paclitaxel for lung cancer and sorafenib for HCC, stabilized the disease. The concurrent treatment was not tolerated and was discontinued owing to adverse events. Considering our findings, treatment with increased efficacy and lower toxicity for MPMs is warranted.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:2288-8128
2383-5001
2383-5001
DOI:10.17998/jlc.2023.03.03